Cargando…
Lipohypertrophy prevalence and its associated risk factors in insulin-treated patients with type 2 diabetes in North Borneo, Malaysia
BACKGROUND: Insulin-treated diabetes patients are at high risk of developing lipohypertrophy, which can negatively impact treatment outcomes. Early detection of lipohypertrophy is crucial to preventing blood glucose fluctuation. Unfortunately, this clinical issue is often overlooked by nurses, causi...
Autores principales: | Nain, Rose A, Thomas, Deena Clare |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Belitung Raya Foundation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405654/ https://www.ncbi.nlm.nih.gov/pubmed/37554235 http://dx.doi.org/10.33546/bnj.2246 |
Ejemplares similares
-
Prevalence of Lipohypertrophy and its Associations in Insulin-Treated Diabetic Patients
por: Nawaz, Arsalan, et al.
Publicado: (2023) -
Lipohypertrophy in Elderly Insulin-Treated Patients With Type 2 Diabetes
por: Gentile, Sandro, et al.
Publicado: (2020) -
Prevalence of Lipohypertrophy and Associated Risk Factors in Insulin-Treated Patients With Type 2 Diabetes Mellitus
por: Al Ajlouni, Mo’men, et al.
Publicado: (2015) -
Insulin-induced Lipohypertrophy in Patients with Type 1 Diabetes Mellitus Treated with an Insulin Pump
por: Ucieklak, Damian, et al.
Publicado: (2022) -
Prevalence of lipohypertrophy in insulin‐treated diabetes patients: A systematic review and meta‐analysis
por: Deng, Nan, et al.
Publicado: (2017)